Recent MSK Discoveries & Advances

Our Research Impact
Paul Marks Prize for Cancer Research
Recent MSK Discoveries & Advances
Research Awards & Honors
Researcher Interviews
Emeritus Faculty

Recent MSK Discoveries & Advances

Share
Share

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
377 News Items found
In the Clinic
Dermatologist examining skin on the face of older man.
Immunotherapy Drug Shows Promise for Metastatic Merkel Cell Carcinoma

An immunotherapy drug might be an effective initial treatment for people with metastatic Merkel cell carcinoma.
Q&A
Hand points to brain scan
New Classification System Will Improve Diagnosis and Treatment of Brain Tumors

There are more than 100 subtypes of brain tumors, making them a challenge to accurately diagnose. Now researchers have figured out a way to reliably distinguish them.
In the Clinic
Chemical biologist Gabriela Chiosis in a laboratory
Experimental Cancer Drug Developed at MSK Leads to New Approach for Treating Alzheimer's Disease

A family of drugs developed at MSK targets disrupted processes in cells in diseases related to aging.
In Brief
Illustration of girl standing in front of charging bull
Scientists Identify How Gene Mutation Drives a Deadly Childhood Cancer

Synovial sarcoma is an aggressive cancer primarily affecting children and young adults. A new study gets to the bottom of it.
In the Clinic
Illustration of a female doctor touching a strand of DNA
New MSK Initiative Focuses on the Early Detection and Prevention of Cancer

Because cancer is more treatable when it’s caught early, MSK’s new Precision Interception and Prevention initiative focuses on early detection.
Q&A
Molecular model of olaparib
The Latest on Genetic Testing for BRCA Mutations in Breast Cancer

An MSK medical oncologist and geneticist discusses the latest drug approved for breast cancer and how genetic testing can lead to new treatments.
In the Clinic
Bob Fontaine (with daughter Mariah, mother Margaret, and wife Ann) credits Dr. Ariyan's trial with saving his life.
After Isolated Limb Infusion, People with Melanoma Get a Second Chance at Life

Meet three people who were treated as part of a clinical trial for melanoma at Memorial Sloan Kettering.
In the Clinic
Jedd Wolchok and Charlotte Ariyan in the lab
Chemotherapy-Immunotherapy Combination Aims to Knock Out Melanoma with a One-Two Punch

A new approach for treating melanoma combines the immunotherapy drug ipilimumab with chemotherapy that treats only the area affected by cancer.
In the Clinic
Medical oncologist Jae Park
Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects

The study represents 20 years of research at MSK.
In the Clinic
A yellow molecular model of the androgen receptor on brown background
An Unlikely Treatment for Triple-Negative Breast Cancer: Prostate Cancer Drugs

Doctors are developing treatment strategies that target the androgen receptor, which is found in many triple-negative breast cancers.